ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 228155 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 228155; 2) Community: the network communities that were significantly associated with the response to NSC 228155; 3) Molecule: the relationships between components within communities and NSC 228155; 4) MDR: the compounds that were significantly associated with the NSC 228155.

NSC Compound Enrichment Correlation
NSC 761834 (Z)-5-chloro-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one 0.0410413740044188 0.3095116
NSC 16166 Azure B bromide 0.0423559437159354 0.21901191
NSC 620674 Null 0.0423559437159354 -0.39661926
NSC 628918 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide . Hydrochloride 0.0423559437159354 0.43973086
NSC 671409 Null 0.0423559437159354 -0.25054913
NSC 736829 6-(5-Aminopentyl)-5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]i soquinoline Hydrochloride 0.0423559437159354 0.42673124
NSC 642316 ANTINEOPLASTIC-642316 0.0423559437159355 -0.019171611
NSC 72942 DL-Noformicin 0.0423559437159355 -0.19520963
NSC 76519 Inosine, 6-thio-, 2',3',5'-tris(4-methoxybenzoate) 0.0423559437159355 0.057828561
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0457230037898003 0.65894539
Total:56  Current:55    [First] [Prev] [Next] [Last]